ENROTAS 10

Each ml contains:
Enrofloxacin. 100 mg
Excipients. q.s.

Treatment of severe respiratory tract infections, including BRD and pneumonia.
Management of complicated infections of the digestive tract (e.g., colibacillosis).
Effective against systemic infections like septicemia and surgical wound infections.
Control of mastitis, metritis, and urinary tract infections.
Highly effective against pathogens resistant to first-line antibiotics.

Enrofloxacin is a bactericidal antibiotic that acts by interfering with essential bacterial DNA replication. It achieves this by inhibiting two vital bacterial enzymes: DNA Gyrase (Topoisomerase II) and Topoisomerase IV. DNA Gyrase is crucial for relaxing supercoiled DNA, and its inhibition prevents the bacteria from replicating or repairing its genetic material. This rapid disruption of DNA integrity leads to irreversible damage and the swift death of the bacterial cell, classifying Enrofloxacin as a potent, concentration-dependent killer.

Potent bactericidal action for quick pathogen elimination.
Broadest spectrum in its class, effective against critical bacteria.
Excellent tissue penetration, reaching difficult sites like the lungs.
Rapid reduction of fever and clinical signs of disease.
Concentrated dose simplifies administration in larger animals.

Cattle/Buffaloes: 0.5 - 1.0 ml per 40 kg body weight. S.C or I.M. route.
Sheep/Goats/Swine: 1 ml per 20 kg body weight. I.M. route.
Treatment duration is typically 3-5 days. Consult a veterinarian for precise dosing.

50 ml, 100 ml vial

Injection